162 related articles for article (PubMed ID: 36369981)
1. Repeatability of ventricular arrhythmia characteristics on the exercise-stress test in RYR2-mediated catecholaminergic polymorphic ventricular tachycardia.
Peltenburg PJ; Pultoo SNJ; Tobert KE; Bos JM; Lieve KVV; Tanck M; Clur SB; Blom NA; Ackerman MJ; Wilde AAM; van der Werf C
Europace; 2023 Feb; 25(2):619-626. PubMed ID: 36369981
[TBL] [Abstract][Full Text] [Related]
2. Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Associated With Ryanodine Receptor (RyR2) Gene Mutations - Long-Term Prognosis After Initiation of Medical Treatment.
Kawata H; Ohno S; Aiba T; Sakaguchi H; Miyazaki A; Sumitomo N; Kamakura T; Nakajima I; Inoue YY; Miyamoto K; Okamura H; Noda T; Kusano K; Kamakura S; Miyamoto Y; Shiraishi I; Horie M; Shimizu W
Circ J; 2016 Aug; 80(9):1907-15. PubMed ID: 27452199
[TBL] [Abstract][Full Text] [Related]
3. Different responses to exercise between Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia.
Inoue YY; Aiba T; Kawata H; Sakaguchi T; Mitsuma W; Morita H; Noda T; Takaki H; Toyohara K; Kanaya Y; Itoi T; Mitsuhashi T; Sumitomo N; Cho Y; Yasuda S; Kamakura S; Kusano K; Miyamoto Y; Horie M; Shimizu W
Europace; 2018 Oct; 20(10):1675-1682. PubMed ID: 29309601
[TBL] [Abstract][Full Text] [Related]
4. Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients.
Faggioni M; Hwang HS; van der Werf C; Nederend I; Kannankeril PJ; Wilde AA; Knollmann BC
Circ Res; 2013 Feb; 112(4):689-97. PubMed ID: 23295832
[TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
Priori SG; Napolitano C; Memmi M; Colombi B; Drago F; Gasparini M; DeSimone L; Coltorti F; Bloise R; Keegan R; Cruz Filho FE; Vignati G; Benatar A; DeLogu A
Circulation; 2002 Jul; 106(1):69-74. PubMed ID: 12093772
[TBL] [Abstract][Full Text] [Related]
6. Diverse Phenotypic Manifestations in a Family with a Novel RYR2 E4107A Variant.
Hasegawa H; Tamura S; Nakajima T; Kawabata-Iwakawa R; Kobari T; Matsumoto N; Sano Y; Nishiyama M; Kurabayashi M; Kaneko Y; Nakatani Y; Ishii H
Int Heart J; 2024; 65(3):580-585. PubMed ID: 38825499
[TBL] [Abstract][Full Text] [Related]
7. A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T>G for 6 years in a 9-year-old child.
Duan H; Lu Y; Yan S; Qiao L; Hua Y; Li Y; Zhou K; Wang C
Medicine (Baltimore); 2018 Apr; 97(16):e0368. PubMed ID: 29668588
[TBL] [Abstract][Full Text] [Related]
8. Exercise testing oversights underlie missed and delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia in young sudden cardiac arrest survivors.
Giudicessi JR; Ackerman MJ
Heart Rhythm; 2019 Aug; 16(8):1232-1239. PubMed ID: 30763784
[TBL] [Abstract][Full Text] [Related]
9. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B
J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944
[TBL] [Abstract][Full Text] [Related]
10. Differential Diagnosis Between Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome Type 1 - Modified Schwartz Score.
Ozawa J; Ohno S; Fujii Y; Makiyama T; Suzuki H; Saitoh A; Horie M
Circ J; 2018 Aug; 82(9):2269-2276. PubMed ID: 29925740
[TBL] [Abstract][Full Text] [Related]
11. Chronotropic incompetence as a risk predictor in children and young adults with catecholaminergic polymorphic ventricular tachycardia.
Franciosi S; Roston TM; Perry FKG; Knollmann BC; Kannankeril PJ; Sanatani S
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1923-1929. PubMed ID: 31231889
[TBL] [Abstract][Full Text] [Related]
12. Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia.
Marjamaa A; Laitinen-Forsblom P; Lahtinen AM; Viitasalo M; Toivonen L; Kontula K; Swan H
BMC Med Genet; 2009 Feb; 10():12. PubMed ID: 19216760
[TBL] [Abstract][Full Text] [Related]
13. Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.
Shan J; Xie W; Betzenhauser M; Reiken S; Chen BX; Wronska A; Marks AR
Circ Res; 2012 Aug; 111(6):708-17. PubMed ID: 22828895
[TBL] [Abstract][Full Text] [Related]
14. Bradycardia Is a Specific Phenotype of Catecholaminergic Polymorphic Ventricular Tachycardia Induced by RYR2 Mutations.
Miyata K; Ohno S; Itoh H; Horie M
Intern Med; 2018 Jul; 57(13):1813-1817. PubMed ID: 29434162
[TBL] [Abstract][Full Text] [Related]
15. Current management of inherited arrhythmia syndromes associated with the cardiac ryanodine receptor.
Przybylski R; Abrams DJ
Curr Opin Cardiol; 2023 Jul; 38(4):390-395. PubMed ID: 37016946
[TBL] [Abstract][Full Text] [Related]
16. Mechanism underlying catecholaminergic polymorphic ventricular tachycardia and approaches to therapy.
Watanabe H; Knollmann BC
J Electrocardiol; 2011; 44(6):650-5. PubMed ID: 21872879
[TBL] [Abstract][Full Text] [Related]
17. Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.
van der Werf C; Nederend I; Hofman N; van Geloven N; Ebink C; Frohn-Mulder IM; Alings AM; Bosker HA; Bracke FA; van den Heuvel F; Waalewijn RA; Bikker H; van Tintelen JP; Bhuiyan ZA; van den Berg MP; Wilde AA
Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):748-56. PubMed ID: 22787013
[TBL] [Abstract][Full Text] [Related]
18. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations.
Swan H; Laitinen P; Kontula K; Toivonen L
J Cardiovasc Electrophysiol; 2005 Feb; 16(2):162-6. PubMed ID: 15720454
[TBL] [Abstract][Full Text] [Related]
19. Intravenous epinephrine infusion test in diagnosis of catecholaminergic polymorphic ventricular tachycardia.
Marjamaa A; Hiippala A; Arrhenius B; Lahtinen AM; Kontula K; Toivonen L; Happonen JM; Swan H
J Cardiovasc Electrophysiol; 2012 Feb; 23(2):194-9. PubMed ID: 21954897
[TBL] [Abstract][Full Text] [Related]
20. Sudden death after inappropriate shocks of implantable cardioverter defibrillator in a catecholaminergic polymorphic ventricular tachycardia case with a novel RyR2 mutation.
Itoh H; Murayama T; Kurebayashi N; Ohno S; Kobayashi T; Fujii Y; Watanabe M; Ogawa H; Anzai T; Horie M
J Electrocardiol; 2021; 69():111-118. PubMed ID: 34656916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
